全文获取类型
收费全文 | 39248篇 |
免费 | 2739篇 |
国内免费 | 457篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 734篇 |
妇产科学 | 524篇 |
基础医学 | 5582篇 |
口腔科学 | 578篇 |
临床医学 | 2515篇 |
内科学 | 9477篇 |
皮肤病学 | 541篇 |
神经病学 | 591篇 |
特种医学 | 207篇 |
外国民族医学 | 2篇 |
外科学 | 1659篇 |
综合类 | 2700篇 |
现状与发展 | 3篇 |
一般理论 | 19篇 |
预防医学 | 12898篇 |
眼科学 | 154篇 |
药学 | 2766篇 |
6篇 | |
中国医学 | 331篇 |
肿瘤学 | 1081篇 |
出版年
2024年 | 54篇 |
2023年 | 915篇 |
2022年 | 1552篇 |
2021年 | 1599篇 |
2020年 | 1543篇 |
2019年 | 1552篇 |
2018年 | 1664篇 |
2017年 | 1586篇 |
2016年 | 1678篇 |
2015年 | 1645篇 |
2014年 | 2266篇 |
2013年 | 4180篇 |
2012年 | 2056篇 |
2011年 | 2380篇 |
2010年 | 2029篇 |
2009年 | 1951篇 |
2008年 | 1649篇 |
2007年 | 1794篇 |
2006年 | 1620篇 |
2005年 | 1196篇 |
2004年 | 1110篇 |
2003年 | 1047篇 |
2002年 | 834篇 |
2001年 | 734篇 |
2000年 | 632篇 |
1999年 | 518篇 |
1998年 | 400篇 |
1997年 | 413篇 |
1996年 | 253篇 |
1995年 | 225篇 |
1994年 | 206篇 |
1993年 | 206篇 |
1992年 | 174篇 |
1991年 | 162篇 |
1990年 | 140篇 |
1989年 | 138篇 |
1988年 | 91篇 |
1987年 | 64篇 |
1986年 | 36篇 |
1985年 | 51篇 |
1984年 | 27篇 |
1983年 | 15篇 |
1982年 | 16篇 |
1981年 | 11篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1974年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
Dr. med. H. Albrecht H.-J. Stellbrink S. Fenske J. Koch H. Greten 《Journal of molecular medicine (Berlin, Germany)》1993,71(4):310-313
Summary Atypical pulmonary manifestations of Pneumocystis carinii infection and fair numbers of extrapulmonary and disseminated infections have lately been documented in patients with human immunodeficiency virus infection treated prophylactically with inhalative pentamidine. We report the case of a 32-year-old homosexual patient who was assessed for complaints of night sweats, weight loss, and progressive malaise. The patient denied any respiratory tract symptoms such as cough, sputum production, pleuritic chest pain, or shortness of breath. Chest X-ray revealed two large round noncavitating lesions in the lower lobe of the right lung. Pneumocystomas were diagnosed by fine-needle aspiration. A 3-week course of intravenous high-dose cotrimoxazole resulted in amelioration of symptoms but no change in the radiographic appearance of the pulmonary lesions. Four months later the patient is alive and stable and is being treated with pentamidine inhalation of 300 mg per 2 weeks and two tablets of pyrimethamine sulfadoxine per week.Abbreviations PcP
Pneumocystis carinii pneumonia
- Pc
Pneumocystis carinii
- AIDS
acquired immunodeficiency syndrome
- HIV
human immunodeficiency virus 相似文献
93.
Efficacy of HIV-specific and 'antibody-independent' mechanisms for complement activation by HIV-infected cells. 总被引:1,自引:0,他引:1 下载免费PDF全文
Previous studies in this laboratory have shown that efficient activation of complement (C) on HIV isolates and HIV-infected cells requires the binding of specific anti-HIV antibodies, while other investigators have observed 'antibody-independent' C activation. In an attempt to clarify these disparate findings, we investigated the effect of several variables on C activation by HIV-infected cells using flow cytometric analysis of C3 deposition. Antibody-mediated C activation using pooled sera from infected persons or human MoAbs directed against the V3 region of gp120 was always substantially higher than activation without antibody. Normal human serum (NHS) from a subset of HIV antibody-negative donors did, however, induce low levels of C3 deposition. Differences in C3 activation between the various NHS did not correlate with total haemolytic C levels or mannose-binding protein (MBP) levels. IgM isolated from NHS that induced high levels of C activation was at least partly responsible for the 'antibody-independent' C activation. Although there appeared to be a correlation between NHS that induced C activation and the presence of anti-blood type B IgM, absorption of anti-B did not abrogate the C3 deposition. Additionally, MoAb to the B antigen did not induce C3 deposition. These studies show that IgM in sera from HIV-uninfected donors can induce C3 deposition on HIV-infected cells, but that specific antibody-dependent C activation is substantially more efficient. Therefore, 'antibody-independent' C activation on HIV-infected cells may, in some cases, be more accurately described as HIV-cross-reactive antibody-dependent C activation. 相似文献
94.
Logan Banner Rao Ernstoff Wolmark Whiteside Miketic Kirkwood 《Clinical and experimental immunology》1998,114(3):347-354
A patient with von Hippel Lindau disease, bilateral symmetric renal cell carcinoma and pulmonary metastases treated with immunotherapy is the subject of this study. A left kidney and tumour mass were removed and the tumour cells used to make an autologous tumour/bacille Calmette–Guérin (BCG) vaccine as part of the treatment protocol. The patient's pulmonary nodules responded, but the remaining renal nodule subsequently grew. Samples of both tumours were obtained allowing for an internally controlled evaluation of the histological and immunohistologic differences between a responding and non-responding tumour nodule after therapy. The immunotherapy protocol is designed to promote a T cell response to autologous tumour. Cellular infiltrates were demonstrated in both responding and non-responding nodules compared with the pretreatment tumour specimen, but the responding nodule contained proportionately more T cells as well as markedly increased numbers of plasma cells and granulocytes. This suggested that several arms of the immune system may have been operative in the responding nodule. 相似文献
95.
Synergistic effect of interleukin-2 and a vaccine of irradiated melanoma cells transfected to secrete staphylococcal enterotoxin A 总被引:4,自引:0,他引:4
We have previously reported that immunization of mice with melanoma cells transfected to secrete the superantigen, Staphylococcal enterotoxin A (SEA), increased the production of antibodies to the B700 melanoma antigen, stimulated the production of endogenous interleukin 2 (IL-2), activated the expression of CD4, CD8 and CD25 T cell markers and enhanced NK cell activity. Now we show that immunization of mice with a vaccine of irradiated sea-transfected melanoma cells coupled with IL-2 therapy was even more effective in inhibiting the growth of primary melanoma tumors and the development of lung metastases than was the irradiated melanoma cell vaccine alone or IL-2 alone. The morphological and immunological effectiveness of the therapy was dose-dependent on IL-2. 相似文献
96.
97.
Alvarez M García F Martínez NM Hernández Quero J Louwagie J De Brauwer A Maroto MC 《Journal of medical virology》2004,73(2):151-157
The changes in viral load and CD4(+) count at 3 and 6 months in a group of 166 HIV-infected patients was evaluated. The new therapy was chosen based on the medical history procedures for 70 patients, and in 96 patients it was guided by the partial or complete result of the line probe assay (LiPA) HIV RT and Protease resistance tests. The absolute difference from the baseline of the log viral load at 3 and 6 months was significantly different between the two groups when adjusted for baseline viral load (P < 0.0001) and stayed significant when intention-to-treat analysis was carried out (P < 0.001). The absolute difference of the CD4(+) count was not significantly different when adjusted for baseline CD4(+) (P = 0.854, 3 months; P = 0.06, 6 months). The proportion of patients with a viral load =200 cp/ml in the medical history group (14.5%, 3 months; 15.2%, 6 months) was significantly different from the proportion of responders in the LiPA group (28.7%, 3 months, P = 0.03; 34.7%, 6 months, P = 0.008). In the intention-to-treat population, the difference between the two groups remained significant (P = 0.01). There was no statistical difference between the two groups in terms of adherence (P = 0.88), number of drug failures (P = 0.12) and for the time since starting treatment (in years) (P = 0.48), but there was a significant difference for the number of new drugs in the new regimen (P < 0.0001) and for the pill burden of the treatment (P = 0.0006). A higher antiretroviral HIV treatment success guided by the LiPA HIV genotyping system than that based on the medical history only is reported. Of note, this study reached the same conclusions as previous studies, which all used sequencing. 相似文献
98.
Children with recurrent lower respiratory tract infection (RLRI) may respond poorly to polysaccharide antigens. To examine how such children respond to a polysaccharide coupled to a protein carrier, we immunized 15 children with RLRI aged 8–69 months and 15 carefully age-matched healthy controls once with a Haemophilus influenzae type b (Hib) conjugate vaccine. Total IgG subclasses, total antipolysaccharide Hib antibodies, and antipolysaccharide Hib antibodies of IgM, IgG, IgA, and IgG 1–4 specificity were determined by ELISA. There were no significant differences between the two groups in any single total IgG subclass, but total IgG measured as the sum of all four subclasses was significantly lower in the children with RLRI than in the controls ( P = 0.036). Before vaccination, the children with RLRI had significantly less IgG antipolysaccharide Hib antibody than the controls ( P = 0.005), whereas 1 month later they had significantly more IgM antibody (P = 0.038). No other significant differences were found between the groups before or after immunization with respect to antipolysaccharide Hib antibodies. Since naturally occurring IgG antibodies are thought to be aquired partly as a consequence of antigenic stimulation on mucosal surfaces, we hypothesize that the low level of specific IgG found before immunization, as well as the low total IgG in the children with RLRI, may reflect an impaired ability to prime through mucosal surfaces. This is supported by our finding of an increased IgM response to Hib conjugate vaccine in these children, since this isotype predominates in the primary immune response, i.e., in the absence of immunologic memory. In conclusion, children with RLRI can be protected against invasive Hib infection as well as healthy children, but may have an immunodeficiency characterized by defective ability to respond to antigenic stimulation on mucosal surfaces. 相似文献
99.
我们已经在减毒鼠伤寒沙门菌SL3261以融合蛋白的形式表达了人工合成的恶性疟原虫杂合113肽基因AB(GZ-AB)。活菌以2×109CFU经口服免疫新西兰家兔,用ELISA测定抗体水平,结果于首次免疫或加强免疫后都可检测到一定水平的特异性抗体。所免疫的家免可以诱发针对恶性疟原虫抗原及GZ-AB的迟发性超敏反应(DTH)。我们的研究表明,含有多个恶性疟原虫抗原表位的人工合成基因可以在减毒鼠伤寒沙门菌中表达,活菌可诱发家兔产生特异的体液免疫及细胞免疫,为恶性疟口服活菌苗的制备打下基础。 相似文献
100.
Systemically administered DNA encoding a recombinant human immunodeficiency virus (HIV) derived immunogen effectively primes a cytotoxic T lymphocyte (CTL) response in macaques. In this further pilot study we have evaluated mucosal delivery of DNA as an alternative priming strategy. Plasmid DNA, pTH.HW, encoding a multi-CTL epitope gene, was incorporated into poly(D,L-lactic-co-glycolic acid) microparticles of less than 10 microm in diameter. Five intrarectal immunizations failed to stimulate a circulating vaccine-specific CTL response in 2 Mamu-A*01(+) rhesus macaques. However, 1 week after intradermal immunization with a cognate modified vaccinia virus Ankara vaccine MVA.HW, CTL responses were detected in both animals that persisted until analysis postmortem, 12 weeks after the final boost. In contrast, a weaker and less durable response was seen in an animal vaccinated with the MVA construct alone. Analysis of lymphoid tissues revealed a disseminated CTL response in peripheral and regional lymph nodes but not the spleen of both mucosally primed animals. 相似文献